Starting on:
Mar 24, 2026
Ending on:
Mar 24, 2026
Moderator(s):
Zoom ID:814 0218 0554
Max Credits:
5 Points
Provider:
Kenya Psychiatrists Association
Claim Points
Mar 24, 2026
Ending on:
Mar 24, 2026
Moderator(s):
Dr.
Stacy Njani
Residence Psychiatry UoN
Venue: Residence Psychiatry UoN
Zoom ID:814 0218 0554
Max Credits:
5 Points
Provider:
Kenya Psychiatrists Association
Claim Points
Management of Refractory Depression
Starting on:
Mar 24, 2026
Mar 24, 2026
Ending on:
Mar 24, 2026
Mar 24, 2026
Venue:
Zoom ID:814 0218 0554
Zoom ID:814 0218 0554
Description
This symposium will explore the complexities of managing refractory or treatment-resistant depression, focusing on the challenges of inadequate response to conventional antidepressant therapies. It will examine current evidence-based approaches to assessment, diagnosis, and treatment optimization, including pharmacological strategies, augmentation therapies, psychotherapy, and emerging interventions. Emphasis will be placed on individualized treatment planning, multidisciplinary collaboration, and improving clinical outcomes and quality of life for patients with persistent depressive symptoms.
Objectives
By the end of the symposium, participants should be able to:
1. Understand the definition, clinical characteristics, and contributing factors associated with treatment-resistant depression.
2. Identify appropriate assessment strategies to distinguish true treatment resistance from inadequate treatment trials, poor adherence, comorbidities, and diagnostic complexities.
3. Evaluate evidence-based pharmacological interventions, including antidepressant switching, combination strategies, and augmentation therapies.
4. Discuss the role of non-pharmacological and emerging treatment options, including cognitive behavioural therapy (CBT), electroconvulsive therapy (ECT), repetitive transcranial magnetic stimulation (rTMS), and ketamine-based interventions.
5. Apply individualized, evidence-based management strategies to optimize treatment response, address relapse risk, improve functional recovery, and enhance the quality of life of patients with refractory depression.
Presenters
-
Dr.
Eva Mucheru
Consultant Psychiatrist